Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GS-CDA1 and MDX-1388 for C. difficile infection
NCT00350298Phase 2Completed
- Sponsor
- MassBiologics
- Start
- Jul 2006
- Primary completion
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of actoxumab, bezlotoxumab in Clostridium difficile infection (CDI), sponsored by MassBiologics. Started Jul 2006; status: completed.
02
Drugs
actoxumabbezlotoxumab
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT00350298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00350298.